Mirae Asset Global Investments Co., Ltd. Uro Gen Pharma Ltd. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,781 shares of URGN stock, worth $36,065. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,781
Previous 1,456
22.32%
Holding current value
$36,065
Previous $16,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding URGN
# of Institutions
163Shares Held
39.6MCall Options Held
2.06MPut Options Held
717K-
Rtw Investments, LP New York, NY4.54MShares$92 Million0.96% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A63.19MShares$64.6 Million0.08% of portfolio
-
Morgan Stanley New York, NY2.48MShares$50.2 Million0.0% of portfolio
-
Jefferies Financial Group Inc. New York, NY2.2MShares$44.5 Million0.27% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$44.4 Million0.0% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $460M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...